Hadron Therapy in Latin America

A.J. KREINER; J. BERGUEIRO; A.A. BURLON; H. DI PAOLO; W. CASTELL; V. THATAR VENTO; P. LEVINAS; D. CARTELLI; J.M. KESQUE; A.A. VALDA; J.C. ILARDO; M. BALDO; J. ERHARDT; M.E. DEBRAY; H.R. SOMACAL; D.M. MINSKY; L. ESTRADA; A. HAZARABEDIAN; F. JOHANN; J.C. SUAREZ SANDIN; M. IGARZABAL; H. HUCK; M. REPETTO; M. OBLIGADO; J. LELL; J. PADULO; M. HERRERA; S.R. GONZALEZ; M.E. CAPOULAT; J. DAVIDSON; M. DAVIDSON

AIP CONFERENCE PROCEEDINGS

American Institute of Pysics

Año: 2010 vol. 1265 p. 363 - 370

0094-243X

The use of proton and heavy ion beams for radiotherapy is a well established cancer treatment modality in the first world, which is becoming increasingly widespread, due to its clear advantages over conventional photon-based treatments. This strategy is suitable when the tumor is spatially well localized. Also the use of neutrons has tradition. Here Boron Neutron Capture Therapy (BNCT) stands out, though on a much smaller scale, being a promising alternative for tumors which are diffuse and infiltrating. On this sector, so far only nuclear reactors have been used as neutron sources. In this paper we briefly describe the situation in Latin America and in particular we discuss the present status of an ongoing project to develop a folded Tandem-ElectroStatic-Quadrupole (TESQ) accelerator for Accelerator-Based (AB)-Boron Neutron Capture Therapy (BNCT) at the Atomic Energy Commission of Argentina. The project goal is a machine capable of delivering 30 mA of 2.4 MeV protons to be used in conjunction with a neutron production target based on the 7Li(p,n)7Be reaction. These are the specifications needed to produce sufficiently intense and clean epithermal neutron beams to perform BNCT for deep-seated tumors in less than an hour. The machine being currently designed and constructed is a folded TESQ with a terminal at 0.6 MV as a smaller scale prototype. Since the concept is modular the same structure will be used for the 1.2 MV final accelerator.